The effect of p-chloroamphetamine on motility in rats after inhibition of monoamine synthesis, storage, uptake and receptor interaction.
D000639:Amitriptyline / Q000494:pharmacology; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000096:biosynthesis*; D002395:Catecholamines / Q000494:pharmacology*; D002713:Chlorine / Q000494:pharmacology; D002744:Chlorpheniramine / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003891:Desipramine / Q000494:pharmacology; D003984:Dibenzazepines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004316:Doxepin / Q000494:pharmacology; D005260:Female; D006220:Haloperidol / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects*; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects; D012702:Serotonin Antagonists; D013141:Spiro Compounds / Q000494:pharmacology; D013997:Time Factors
D001679:Biogenic Amines; D002395:Catecholamines; D003984:Dibenzazepines; D008781:Methyltyrosines; D011950:Receptors, Cholinergic; D012702:Serotonin Antagonists; D013141:Spiro Compounds; D004316:Doxepin; D000639:Amitriptyline; D002744:Chlorpheniramine; D002713:Chlorine; D000661:Amphetamine; D006220:Haloperidol; D007099:Imipramine; D003891:Desipramine; D002746:Chlorpromazine